Riskpilot← Back to searchSign inGet full accessTixident Oy
OYDissolvedY-tunnus 1536867-6Puunkaatajantie 5-AManufacture of medical and dental instruments and supplies · NACE 3250Est. 19990 employees
Revenue 2025
EUR 2K
-100% vs 2024
EBITDA margin
37.7%
-100% vs 2024
Equity ratio
—
Financial strength
Net profit 2025
EUR 2K
-100% vs 2024
| Revenue | EUR 2K | -100% |
| EBITDA | EUR 889 | -100% |
| Net profit | EUR 2K | -100% |
| Total assets | EUR 19K | — |
| Equity | EUR 0 | — |
| Employees | 0 | — |
Legal name
Tixident Oy
Y-tunnus number
1536867-6
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
31. toukokuuta 1999
Share capital
EUR 8 409
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Hammasteknisten töiden valmistus, korjaus ja hammasteknisten tarvikkeiden maahantuonti ja myynti sekä kiinteistöjen ja osakkeiden omistus ja hallinta.
Address
Puunkaatajantie 5-A
Phone
+3580407034533
Email
tixident@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 158 | 106 | 0 | 2 793 | 2 |
| Staff expenses | −69 | −50 | −50 | −874 | −94 162 |
| EBITDA | 32 | 18 | 0 | 1 318 | 1 |
| Depreciation & amort. | −1 | −1 | −1 | −35 | −0 |
| EBIT | 31 | 17 | 0 | 1 283 | 1 |
| Net financials | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 32 | 17 | 0 | 1 283 | 2 |
| Tax | 6 | 3 | −0 | −190 | 0 |
| Net profit | 25 | 14 | 0 | 1 472 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 53 | 36 | 6 | 0 | 19 |
| Equity | 38 | 29 | 0 | 0 | 0 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 15 | 7 | 5 | 1 132 | 0 |
| Total debt | 15 | 7 | 0 | 0 | 0 |
EBITDA margin
37.7%
This company
15.8%
Market median
+139% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
157500.0%
This company
18.4%
Market median
+855878% vs market
20212025
Net profit margin
66.7%
This company
8.1%
Market median
+723% vs market
20212025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20212025
Debt / equity
19202.00×
This company
0.62×
Market median
-3096997% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
PC Deputy auditor | Deputy auditor | 2021 |
SK Deputy Member | Deputy Member | 2021 |
SP Audit | Audit | 2021 |
| Former (3) | ||
EI Deputy auditor | Deputy auditor | 1999 – 2021 |
TK Audit | Audit | 1999 – 2021 |
AJ Deputy Member | Deputy Member | 1999 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 1999 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tixident Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Irmeli Lohtari-Keskilä | Deputy auditor | 0 companies |
| Pasi Christian Klemetti | Deputy auditor | 0 companies |
| Timo Kalervo Keskilä | Audit | 0 companies |
| Sari-Mari Kyhyräinen | Deputy Member | 0 companies |
| Sini Päivi Heikkinen | Audit | 0 companies |
| Antti Juhani Mäkelä | Deputy Member | 0 companies |
| Jukka Antero Kyhyräinen | Board of Directors | 0 companies |